Clinical Trial Update: A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population

View source ↗

Summary

This clinical trial update describes a study assessing pregnancy outcomes in women exposed to Dayvigo (lemborexant) during pregnancy compared to an unexposed co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Dayvigo (lemborexant)

Snippet

Sponsor: Eisai Inc. | Conditions: Sleep Initiation and Maintenance Disorders, Pregnancy | Status: ACTIVE_NOT_RECRUITING